Resources

Often our patients with diabetes have unexplained hypoglycemia and there seems to be no rhyme or reason as to why. Sheri Colberg, Ph.D., FACSM has the latest research on what happens to cause this. Read Exercise and Hypoglycemia: Their Effect on Hormonal Responses

Researchers have successfully induced human insulin-producing cells, known as beta cells, to replicate robustly in a living animal, as well as in the lab. The discovery not only could improve models and methods for studying diabetes, but also opens up new possibilities for treating the condition.

Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors or ARBs can slow rates of progression of diabetic nephropathy.  

This parental history is also associated with increased rates of metabolic syndrome and a metabolic syndrome related to insulin resistance.

The FDA has finalized guidelines that will allow pharmaceutical and device company reps to distribute journal articles to doctors about off-label uses of their products.

A meta-analysis of pedometer-based walking interventions shows how effective a pedometer can be in reducing weight.

If doctors start taking results of a recent drug company-sponsored trial seriously, 11 million more older Americans might be taking cholesterol-lowering statin medications, experts say.

Researchers from India and Oregon have taken a step toward developing the first saliva test to detect and monitor how efficient is the treatment for Type 2 diabetes.

A new national study has shown that nearly 75 percent of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk for a cardiovascular event, according to current national cholesterol guidelines.

Many people with type 2 diabetes may be skeptical about the safety and effectiveness of their medications, African Americans in particular, a new study suggests.